Cell Wars – Dr. Gail McIntyre, Chief Scientific Officer, Aravive – Researching Ways to Combat Disease at the Cellular Level

Finding Genius Podcast

Richard Jacobs

Medicine, Health & Fitness

4.4 • 1K Ratings

🗓️ 10 February 2020

⏱️ 32 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this podcast, Gail McIntyre, Ph.D., DABT, Chief Scientific Officer of Aravive, delivers a comprehensive overview of her work as CSO developing options to treat an assortment of diseases.

Before arriving at Aravive, Dr. McIntyre was a principal and/or consultant at multiple innovative pharmaceutical and biotechnology-oriented companies. Opening the podcast, Dr. McIntyre discusses in detail all the groundbreaking work they are producing at Aravive, developing treatments to stop the progression of life-threatening diseases. Dr. McIntyre explains how the Aravive system is built upon an approach to target influential signaling pathways that sustain the activation, the migration, and eventual invasion of abnormal cells into otherwise healthy tissue.

The scientific officer explains how tumors work to survive in less than ideal environments. She discusses the secretion of interleukins that can affect white cells. She provides a thorough analysis of the varied processes that sometimes work to improve multiple factors for tumor growth that allows them to survive in all kinds of conditions. She talks about their current work studying the effects and impact of select oncology drugs, observing GAS6 levels in monkeys. Dr. McIntyre further explains how select particular doses of drugs can suppress GAS6 levels, specifically in regard to their ongoing study of ovarian cancer.

Dr. McIntyre has authored many regulatory submissions and she is a board-certified toxicologist with noted expertise in oncology and infectious diseases, etc.

Transcript

Click on a timestamp to play from that location

0:00.0	You're listening to the Future Tech Podcast with Richard Jacobs.
0:09.0	Future Technologies such as Artificial Intelligence,
0:11.8	Stem Cells, 3D printing, gene editing,
0:14.7	Bitcoin, blockchain, the microbiome, quantum computing, virtual reality, and exploring space
0:21.0	are much closer than you might think.
0:23.0	In fact, many early versions of these technologies are in play right now,
0:27.0	and the companies that are using these technologies are the focus of this podcast.
0:31.0	My goal for you, the listener, is to learn from these
0:34.4	podcasts. You may very well learn something that may change the course of your life
0:38.2	for the better. Steer you towards a new career or give you insight into
0:42.4	addressing a thorny medical problem.
0:44.4	Remember, this podcast and its content is informational and nature only. No medical,
0:49.2	tax, legal, financial, or psychological advice is being given.
0:53.0	If you've enjoyed the podcast, please listen, subscribe, like, and tell your friends about it.
0:58.0	Thank you. Hello this is Richard Jacobs with the Future Tech and Future Tech
1:08.2	Health Podcast and I have Gail Akintyre she's a chief scientific officer at Aravib. A R-A-V-I-V-E-D-E-D-C-T-G-E-T-G-O-G-E, Gail, thanks for coming, I appreciate it.
1:19.0	Thank you.
1:20.0	What's the premise of Aravibibiby? What's the premise of Eravi? What's the company about?
1:25.0	Well, I think and hopefully you'll appreciate we have very unique technology,
1:30.0	it's clever technology that was licensed from Stanford University.
1:34.0	And unlike other companies that are targeting cell surface receptors,
1:40.0	we actually have a technology that targets a ligand and it's the sole ligand that
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.